France · Delayed Price · Currency is EUR Clariane SE Earnings Call Transcripts
Fiscal Year 2026
-
Solid organic revenue growth of +4.9% in Q1 2026 was driven by improved occupancy, pricing, and strong performance across all segments and geographies. Liquidity was strengthened by a successful EUR 500 million bond issue, and medium-term guidance was confirmed.
Fiscal Year 2025
-
Delivered strong 2025 results with 4.5% organic revenue growth, improved profitability, and reduced leverage. Strategic divestments, cost efficiency programs, and a robust outlook support continued margin and cash flow gains through 2028.
-
Revenue grew 4.9% organically in the first nine months of 2025, with Q3 acceleration and all segments contributing. EBITDA margin is set to reach ~12% in H2, supported by cost reduction and portfolio streamlining, while leverage and CapEx guidance remain unchanged.
-
Solid H1 2025 results with 4.8% organic revenue growth, successful €1B asset disposal, and strengthened liquidity. Guidance for 6–9% EBITDA growth and leverage below 5.5x is confirmed, with margin recovery expected in H2 from pricing and operational improvements.
-
The meeting confirmed strong financial recovery, with sales up 6.6% and net profit returning to positive. Major governance changes included a new Chair and updated remuneration policies. All resolutions passed, and the group continues to focus on debt reduction, asset divestment, and climate adaptation.
-
Q1 2025 organic revenue grew 4.8% (5.5% ex-leap year), with all segments and regions contributing. Asset disposals reached €600 million, targeting €1 billion by end-2025, and 2025 guidance for revenue and EBITDA growth is confirmed. HoldCo leverage is set to fall below 5.5x.
Fiscal Year 2024
-
Revenue grew 6.6% organically to EUR 5.3 billion, with EBITDA at EUR 605 million and margin up 30 bps (excluding real estate development). Net debt fell by EUR 409 million, and over half of the EUR 1 billion disposal plan is complete. 2025 guidance targets 5% organic sales growth, 6–9% EBITDA growth, and further deleveraging.
-
Organic revenue grew 6.3% in the first nine months of 2024, with all segments and regions contributing. Asset disposals progressed, supporting liquidity for upcoming maturities, and occupancy rates continued to rise. Price increases are now the main revenue driver.
-
Revenue grew 6.8% organically in H1 2024, with EBITDA and cash flow improving and net debt reduced by EUR 500 million. Asset disposals and refinancing progressed, outlook reaffirmed, and new build program scaled back to 2,700 pre-financed beds.